Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $10.71 Analyst target: $21.83 Upside: 103.83%
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company is headquartered in Watertown, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.